Skip to content
Menu
Home
About Us
Chairman’s Profile
Board Of Directors
Team Wockhardt
Corporate Milestones
Research & Development
R&D at Wockhardt
New Drug Discovery
Pipeline / Projects
News & Events
Publications
ZAYNICH
®
WCK 4873
WCK 4282
WCK 6777
Biologicals
News & Events
Pipeline / Projects
Publications
R&D Contact
Our Manufacturing Units
Shendra, India
Biotech Park, India
Daman, India
Ankleshwar, India
Global Footprint
India
UK & Europe
Emerging Markets
Products
India Branded Business
API
Russia – CIS
UK
Irish Market
Emerging Markets
Quality Generics
Quality Policy
Investors
From Chairman’s Office
AGM Speech
Letter to Shareowners
Financials
Annual Report
Quarterly Results
Financial Press Releases
Related Party Transactions
Subsidiary Financials
Annual Return
Corporate Governance
Policies & Codes
Committee’s of the Board
Familiarisation programs
Shareholding Pattern
Secretarial Compliance Report
Authorised KMP
Corporate Actions
Memorandum of Association and Article of Association
ESOP Scheme
Disclosures under Regulation 46 of SEBI LODR Regulations
Announcements / Disclosures
Shareholders Meeting / Postal ballot
AGM Notice
Proceedings
Voting Results
Transcript of the AGM
IEPF
Unclaimed Dividend
Nodal Officer
Analyst/ Investors
Presentation
Audio / Video Recording
Transcript
Shareowner Services
FAQ
Green Initiative
Investor Contact
Other Notices
Credit Rating
careers
Introduction
Life@Wockhardt
L&D Initiatives
Voice of Wockhardians
Career@Wockhardt
Media
Press Releases
Wockhardt in Media
ESG
Contact us
Home
/
Investor
/
Page 179
Archives:
Investor
This post type contains { $postTypeName } information
Chairman’s AGM Speech 2012
WOCKHARDT LAUNCHES GENERIC VERSION OF ANTIDEPRESSANT DRUG WELLBUTRIN® SR
WOCKHARDT RECEIVES US FDA APPROVAL FOR GENERIC VERSION OF PARKINSONISM DRUG REQUIP XL®
WOCKHARDT RECEIVES TENTATIVE US FDA APPROVAL FOR GENERIC VERSION OF ANTI – PSYCHOTIC DRUG GECDON®
WOCKHARDT TO LAUNCH GENERIC VERSION OF ANTI – HYPERTENSIVE DRUG PLENDIL®
WOCKHARDT RECEIVES US FDA APPROVAL FOR GENERIC VERSION OF PARKINSON’S DRUG COMTAN®
WOCKHARDT TO LAUNCH GENERIC VERSION OF CLOT BUSTER DRUG PLAVIX®
WOCKHARDT TO LAUNCH GENERIC VERSION OF BPH DRUG UROXATRAL®
Chairman’s letter to shareowners Q1 2012 – 13
Annual report 2012 – 2013
Posts navigation
Previous page
Page
1
…
Page
178
Page
179
Page
180
…
Page
192
Next page
